Our Press Releases
Article Category
Graft-versus-Host Disease (GvHD)
Quick Review over Graft-versus-Host Disease (GvHD) Introduction: Graft-versus-Host Disease (GvHD) is a common complication
Cancer Statistics
Cancer statistics According to the American Cancer Society’s annual estimate of 2021, there will
Multiple sclerosis (MS)
Quick Review over Multiple sclerosis (MS) Multiple sclerosis (MS) is a lifelong, and often
Protein Tyrosine Kinases:Their Roles and Their Targeting in Leukemia
Protein tyrosine kinases superfamily definition A large group of enzymes that speeding up protein
Disease modifying therapies (DMTs)
Quick Review Over Disease Modifying Therapies (DMTs) For Multiple Sclerosis Introduction: Multiple sclerosis (MS)
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell
Type 2 Diabetes Mellitus
Overview of Type 2 Diabetes Mellitus Type 2 diabetes mellitus is the most common
Parsian Pharama Review of CDK4/6 Inhibitors Citing to the Recent Articles
Parsian pharama review of CDK4-6 inhibitors citing to the recent articles One of the
US FDA Approved Empagliflozin
The U.S. FDA Approved Empagliflozin for Wider Range of Patients with Heart Failure